Cancer is a complex disease with significant variability between cases, and as a result, is one of the leading causes of death worldwide. Lung cancer is a particularly difficult form of cancer to diagnose and treat, due largely to the inaccessibility of lung tumours and the limited available treatment options. There is a need for highly targeted, minimally invasive treatment options that facilitate the complete removal of cancer from a patient while minimising damage to non-malignant tissue. The development of plasmonic gold nanoparticles has lead to their potential use in a large range of disciplines, and in particular, they have shown great promise for application in biomedicine. Plasmonic gold nanoparticles possess many desirable cha...
textCancer has become one of the leading causes of death today. The early detection of cancer may le...
textGold nanoparticles, a class of plasmonic nanoparticle, have increasingly been explored as an ima...
Unidade de Ciencias Biomoleculares Aplicadas - UCIBIO - FCT/MEC (UID/Multi/04378/2013) ERDF (POCI-01...
Plasmonic gold nanoparticles show potential for use in a range of cancer diagnostics and therapeutic...
Cancer is the most common cause of death in the UK. Due to its aging population, the rate of cancer ...
AbstractCurrently a popular area in nanomedicine is the implementation of plasmonic gold nanoparticl...
Gold nanorods (AuNRs) have the potential to be used in photoacoustic (PA) imaging and plasmonic phot...
Gold nanorods (AuNRs) have the potential to be used in photoacoustic (PA) imaging and plasmonic phot...
Cancer remains one of the leading causes of death in the world. For a number of neo-plasms, the effi...
The use of lasers, over the past few decades, has emerged to be highly promising for cancer therapy ...
The use of lasers, over the past few decades, has emerged to be highly promising for cancer therapy ...
Nanoparticles of gold, which are in the size range 10-100 nm, undergo a plasmon resonance with light...
The use of lasers, over the past few decades, has emerged to be highly promising for cancer therapy ...
Inadequate therapies and clinical methods for overcoming multidrug-resistant cancer constitute the m...
Cancer is one of the leading causes of death worldwide. In the last two decades, the development of ...
textCancer has become one of the leading causes of death today. The early detection of cancer may le...
textGold nanoparticles, a class of plasmonic nanoparticle, have increasingly been explored as an ima...
Unidade de Ciencias Biomoleculares Aplicadas - UCIBIO - FCT/MEC (UID/Multi/04378/2013) ERDF (POCI-01...
Plasmonic gold nanoparticles show potential for use in a range of cancer diagnostics and therapeutic...
Cancer is the most common cause of death in the UK. Due to its aging population, the rate of cancer ...
AbstractCurrently a popular area in nanomedicine is the implementation of plasmonic gold nanoparticl...
Gold nanorods (AuNRs) have the potential to be used in photoacoustic (PA) imaging and plasmonic phot...
Gold nanorods (AuNRs) have the potential to be used in photoacoustic (PA) imaging and plasmonic phot...
Cancer remains one of the leading causes of death in the world. For a number of neo-plasms, the effi...
The use of lasers, over the past few decades, has emerged to be highly promising for cancer therapy ...
The use of lasers, over the past few decades, has emerged to be highly promising for cancer therapy ...
Nanoparticles of gold, which are in the size range 10-100 nm, undergo a plasmon resonance with light...
The use of lasers, over the past few decades, has emerged to be highly promising for cancer therapy ...
Inadequate therapies and clinical methods for overcoming multidrug-resistant cancer constitute the m...
Cancer is one of the leading causes of death worldwide. In the last two decades, the development of ...
textCancer has become one of the leading causes of death today. The early detection of cancer may le...
textGold nanoparticles, a class of plasmonic nanoparticle, have increasingly been explored as an ima...
Unidade de Ciencias Biomoleculares Aplicadas - UCIBIO - FCT/MEC (UID/Multi/04378/2013) ERDF (POCI-01...